scholarly journals The First Case of Simultaneous Surgical Procedure for Mitral Valve Disease and Esophageal Cancer

2021 ◽  
pp. 1665-1670
Author(s):  
Roman Komarov ◽  
Sergey Osminin ◽  
Alisher Ismailbaev ◽  
Ivan Ivashov ◽  
Yulia Agakina ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Malignant Tumors ◽  
Valve Disease ◽  
Midline Laparotomy ◽  
Ivor Lewis ◽  
First Case ◽  
Median Laparotomy

Cardiological patients with malignant tumors belong to a complex category of patients. We present the world’s first case of simultaneous surgical treatment of severe mitral valve disease and esophageal cancer. The patient underwent simultaneous replacement of the mitral valve and the Ivor-Lewis procedure using right thoracotomy and upper midline laparotomy. The patient underwent 3 courses of chemotherapy (paclitaxel and 5-fluoroucil). Follow-up for 8 months showed no signs of tumor recurrence or cardiac problems. A dextral thoracotomy with the lung deprivation, supplemented by an upper median laparotomy, achieved us convenient access to the mitral valve and to all parts of the esophagus, including groups of compromised lymph nodes. This case demonstrates the modern possibilities of simultaneous cardio and oncosurgery that allows eliminating competitive fatal diseases in 1 surgical and anesthetic intervention.

scholarly journals Mitraclip for high risk patients with barlow mitral valve disease

2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
M Gavazzoni ◽  
M Taramasso ◽  
D Voci ◽  
A Pozzoli ◽  
M Miura ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Left Ventricle ◽  
Mitral Valve Disease ◽  
Nyha Class ◽  
Valve Disease ◽  
Volume Index ◽  
Barlow’S Disease ◽  
The Mean ◽  
Procedural Success

Abstract Background No data have been published to now about the outcomes of MitraClip in inoperable patients with Barlow's Mitral Valve Disease. Despite the technical advantages of the new generation of MitraClips, the length and the thickness of the mitral leaflets and presence of flails with complete eversion and pseudo-cleft are challenging MitraClip procedure. Purpose To analyse the results of MitraClip in inoperable patients with Barlow's disease of Mitral valve. Methods We retrospectively collected the cases of MR in Barlow's disease treated with MitraClip in our institution from 2012 to 2018. The case were included in the analysis in presence of the following characteristics: bileaflet billowing or prolapse [or both], excessive leaflet tissue, and annular dilatation with or without calcification. Results We included in this analysis 59 patients (mean age 78±8 years, STS mortality score 4±2.9%). Echo data at baseline showed normal left ventricle ejection fraction and diastolic volume and increased left atrial volume index. Half of the included patients had a chordal rupture (n=27, 47%) and in 14 patients (23%) calcification of annulus and/or leaflet was diagnosed. The mean procedural time was 92±41min with a technical success (M-VARC) of 100% and more than 80% of patients requiring more than 1 clip. At 30 days follow-up the device success and the procedural success were respectively 59% and 56%. The mean diastolic mitral valve gradient was 3.1±1.5mmHg. At 30 days follow-up, 91% of the patients were NYHA class II stable patients; no death and no hospitalization occurred. During a median follow-up time of 412 days (IQR: 209–992 days) death for any cause occurred in 23% of the patients (n=14) and 16% of the patients (n=10) died because of a cardiovascular cause; 10 patients were re-hospitalized for heart failure and 5% of the patients (n=3) underwent an open-heart surgery at follow-up time. At univariate cox regression analysis the 1-Y composite end-point (death for any cause, HF re-hospitalization, MV surgery) was predicted by LV dimensions and 30 days procedural success. Conclusions To our knowledge, this is the first analysis of outcomes of Barlow's disease treated with MitraClip. Despite a high incidence of MR recurrence, we observed a good clinical response in term of NYHA class and mortality rate. Left ventricle size and 30-day procedural success predict outcomes. Funding Acknowledgement Type of funding source: None

scholarly journals Impact of concomitant tricuspid annuloplasty on right ventricular remodeling in patients with rheumatic mitral valve disease

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Yue Zhong ◽  
Wenjuan Bai ◽  
Hui Wang ◽  
Hong Qian ◽  
Li Rao
Keyword(s):  
Mitral Valve ◽  
Ejection Fraction ◽  
Right Ventricular ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Maze Procedure ◽  
Tricuspid Annuloplasty ◽  
Concomitant Surgery ◽  
And Function

Abstract Background Studies on the management of functional tricuspid regurgitation (TR) during mitral valve operations have drawn inconsistent conclusions. This study was designed to compare the treatment strategy of concomitant tricuspid annuloplasty (TAP) against isolated mitral valve replacement (MVR) in rheumatic mitral valve disease patients, and to assess the effect of concomitant TAP on postoperative right ventricular (RV) remodeling and function. Methods One hundred-seventy patients with rheumatic mitral valve disease receiving MVR were categorized into TAP group (n = 124) and non-TAP group (n = 46). Clinical and echocardiographic data were collected preoperatively and at 1-year follow-up. Three-dimensional echocardiographic indices of RV geometry and function were analyzed. Results At baseline, concomitant TAP group had larger RV end-diastolic volume, more decreased RV ejection fraction and RV longitudinal strain than non-TAP group (all P <  0.001). At 1-year follow-up, TAP group had improved RV geometry and function. While adverse changes were observed in non-TAP group. In analysis of variance, the above indices demonstrated significant interaction with different treatment group (all P <  0.001). In multivariate regression analysis, independent of age and Maze procedure, concomitant TAP was associated with postoperative RV volume reduction (P <  0.001), improvement of RV ejection fraction (P <  0.001), and relieved postoperative functional TR severity (P = 0.025). Conclusions Our results suggest that concomitant TAP could improve RV remodeling and function for rheumatic mitral valve disease patients, while those with mild preoperative functional TR who had isolated MVR might experience RV dilation and deterioration of RV function at follow-up. Concomitant surgery for functional TR could be considered for patients undergoing MVR with rheumatic mitral valve disease.

Ten Years’ Follow-Up of Single-Surgeon Minimally Invasive Reparative Surgery for Degenerative Mitral Valve Disease

2012 ◽  
Vol 7 (4) ◽  
pp. 270-273 ◽  
Author(s):  
Alessandro D'Alfonso ◽  
Filippo Capestro ◽  
Carlo Zingaro ◽  
Sacha Matteucci ◽  
Giuseppe Rescigno ◽  
...  
Keyword(s):  
Mitral Valve ◽  
Minimally Invasive ◽  
Mitral Valve Disease ◽  
Valve Disease

scholarly journals Long-term follow-up of atrial contraction after the maze procedure in patients with mitral valve disease

2001 ◽  
Vol 37 (6) ◽  
pp. 1622-1627 ◽  
Author(s):  
Satoshi Yuda ◽  
Satoshi Nakatani ◽  
Yoshio Kosakai ◽  
Masakazu Yamagishi ◽  
Kunio Miyatake
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Disease ◽  
Valve Disease ◽  
Maze Procedure ◽  
Atrial Contraction ◽  
Long Term Follow Up

Chordal Replacement with Expanded Polytetrafluoroethylene Suture: Early Results

1998 ◽  
Vol 6 (1) ◽  
pp. 49-51 ◽  
Author(s):  
Taweesak Chotivatanapong ◽  
Pradistchai Chaiseri ◽  
Choosak Kasemsarn ◽  
Vibhan Sungkahapong
Keyword(s):  
Mitral Valve ◽  
Mitral Valve Repair ◽  
Mitral Valve Disease ◽  
Thromboembolic Complication ◽  
Valve Disease ◽  
Valve Repair ◽  
Expanded Polytetrafluoroethylene ◽  
Early Results ◽  
Chordal Replacement

Expanded polytetrafluoroethylene suture has been used for chordal replacement to achieve better results of mitral valve repair in patients with severe subvalvular disease. From March 1994 to December 1996, 16 patients with mitral valve disease were successfully repaired with this suture at Central Chest Hospital. There were 10 males and 6 females. The average age was 36.5 years. Mean follow-up was 18.18 months. Mitral valve disease was rheumatic in origin in most patients. The suture was attached to the posterior leaflet in 11 patients and to the anterior leaflet in the other 5. The average number of pairs of sutures used per patient was 1.37 (range 1 to 4 pairs). The average number of surgical procedures for mitral valve repair per patient was 5.1. There was no hospital mortality and no thromboembolic complication or reoperation during this study. Postoperative functional status and mitral regurgitation improved substantially. We concluded from this study that this suture can be used safely and effectively for chordal replacement in mitral valve repair.

scholarly journals Transseptal transcatheter mitral valve replacement

2020 ◽  
Vol 25 (8) ◽  
pp. 3842
Author(s):  
V. I. Ganyukov ◽  
R. S. Tarasov ◽  
I. V. Ganyukov
Keyword(s):  
Case Report ◽  
Mitral Valve ◽  
Valve Replacement ◽  
Mitral Valve Replacement ◽  
Mitral Valve Disease ◽  
Current Data ◽  
Valve Disease ◽  
Less Invasive ◽  
Transcatheter Mitral Valve Replacement

The review presents current data transseptal transcatheter mitral valve replacement, which is becoming an alternative method of managing mitral valve disease. Despite the fact that the transapical transcatheter approach is technically simpler, the transseptal method is less invasive. It has confirmed effectiveness and is predicted to be the most promising. The review describes the relevance, indications, methodology for selecting the required endoprosthesis, stages of procedure, complications, and the postoperative follow-up of patients. The results of publications on transseptal transcatheter mitral valve replacement are analyzed. A case report is given.

Sign in / Sign up

Export Citation Format

Share Document